Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Fischer

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Cancer Research|May 1, 2002
Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor developmentDavid K Bol, R Bruce Rowley, Ching-Ping Ho, et al.
Oncogene|July 13, 2004
Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cellsShaohua Tang, Bobby Bhatia, Jianjun Zhou, et al.
Cell Cycle (Georgetown, Tex.)|July 11, 2013
In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animalsMark A Badeaux, Collene R Jeter, Shuai Gong, et al.
The Journal of Investigative Dermatology|February 1, 2013
Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2Aniruddha Sengupta, Ulrike F Lichti, Bradley A Carlson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2003
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cellsImad Shureiqi, Wei Jiang, Xiangsheng Zuo, et al.
Molecular Carcinogenesis|October 19, 2011
Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glandsJie Tian, Isabel Lambertz, Thomas R Berton, et al.
Neoplasia (New York, N.Y.)|August 2, 2008
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpressionJennifer Kl Colby, Russell D Klein, Mark J McArthur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancerJingjing Gong, Jianping Xie, Roble Bedolla, et al.
Molecular Cancer Research : MCR|July 27, 2014
Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancerJing Jiao, Tomo-O Ishikawa, Darren S Dumlao, et al.
Oncology Reports|February 7, 2012
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancersRonald A Lubet, Margie L Clapper, David L McCormick, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Cancer Research|May 1, 2002
Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor developmentDavid K Bol, R Bruce Rowley, Ching-Ping Ho, et al.
Oncogene|July 13, 2004
Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cellsShaohua Tang, Bobby Bhatia, Jianjun Zhou, et al.
Cell Cycle (Georgetown, Tex.)|July 11, 2013
In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animalsMark A Badeaux, Collene R Jeter, Shuai Gong, et al.
The Journal of Investigative Dermatology|February 1, 2013
Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2Aniruddha Sengupta, Ulrike F Lichti, Bradley A Carlson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2003
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cellsImad Shureiqi, Wei Jiang, Xiangsheng Zuo, et al.
Molecular Carcinogenesis|October 19, 2011
Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glandsJie Tian, Isabel Lambertz, Thomas R Berton, et al.
Neoplasia (New York, N.Y.)|August 2, 2008
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpressionJennifer Kl Colby, Russell D Klein, Mark J McArthur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancerJingjing Gong, Jianping Xie, Roble Bedolla, et al.
Molecular Cancer Research : MCR|July 27, 2014
Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancerJing Jiao, Tomo-O Ishikawa, Darren S Dumlao, et al.
Oncology Reports|February 7, 2012
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancersRonald A Lubet, Margie L Clapper, David L McCormick, et al.
Pageof 9